Antibody Structure, Classes, and Specificity

The basic antibody monomer consists of four polypeptide chains: two identical heavy chains (H) and two identical light chains (L). Heavy chains have a molecular weight of roughly 50 to 70 kDa depending on class; light chains are approximately 25 kDa each and exist in two types, kappa and lambda, whose ratio varies by species. The chains are held together by non-covalent interactions and by interchain disulfide bonds: one between each H and L pair, and one or more between the two H chains at the hinge region.

Each heavy chain is organised into a variable domain (VH) at the amino terminus followed by three or four constant domains (CH1, CH2, CH3, and CH4 in IgM and IgE). Each light chain has one variable domain (VL) and one constant domain (CL). The VH and VL domains pair to form the antigen-binding site. The CDRs within VH and VL create a surface contour, the paratope, that is complementary in shape and charge to the epitope on the antigen. Antibody specificity arises from the precise geometry of this contact, which involves hydrogen bonds, electrostatic interactions, van der Waals forces, and hydrophobic contacts.

Proteolytic digestion with papain cleaves the antibody above the hinge, generating two Fab fragments and one Fc fragment. Pepsin cleaves below the hinge, generating an F(ab')2 fragment (both Fab arms still connected) and small Fc peptides. These fragments are used in forensic and diagnostic reagents when the Fc region is undesirable because it triggers non-specific binding to Fc receptors in tissues or causes background signal in immunohistochemistry.

The five classes, or isotypes, are defined by their heavy-chain constant-region sequences. IgG has the gamma heavy chain, IgA has alpha, IgM has mu, IgD has delta, and IgE has epsilon. Each class has a distinct distribution in the body, a distinct valency (number of antigen-binding sites per molecule), and distinct effector functions. The table below summarises the key properties relevant to forensic applications.

IgG is the workhorse of forensic immunoassay. It is the most abundant immunoglobulin in serum, crosses the placenta (relevant in maternal-fetal DNA and serology contexts), and has a half-life of approximately 21 days in humans. IgG is further divided into four subclasses (IgG1, IgG2, IgG3, IgG4) in humans, each with slightly different hinge structures and complement-activation efficiency. Most commercial forensic reagents are IgG1 monoclonal antibodies because this subclass activates complement efficiently and has high affinity for protein A, which simplifies purification.

IgM pentamers are the natural ABO blood-group antibodies. Anti-A and anti-B found in healthy adults are IgM isohemagglutinins that arise without deliberate immunisation, apparently triggered by cross-reactive bacterial antigens in the gut microbiome. Because IgM has ten antigen-binding sites (two per monomer, five monomers in the pentamer), it agglutinates red cells at low concentrations and at room temperature, which is why forward and reverse ABO typing at room temperature is a standard serological procedure. The ABO blood-group system topic covers the full genetics and testing protocols.

Affinity describes the binding of a single paratope to a single epitope and is expressed as the equilibrium dissociation constant Kd. A Kd of 10 to the power of minus 9 mol/L (1 nanomolar) means the antibody-antigen complex is relatively stable at physiological concentrations; a Kd of 10 to the power of minus 6 mol/L (1 micromolar) represents weaker binding. High-affinity monoclonal antibodies used in forensic drug immunoassays typically have Kd values in the nanomolar range, which is why ELISA and lateral-flow strip methods can detect nanogram-per-millilitre concentrations of drugs or metabolites in urine.

Avidity is the cumulative binding strength of a multivalent antibody interacting with a multivalent antigen. IgM, with ten binding sites, can bind a cell surface carrying multiple copies of the same antigen simultaneously. Even if each individual site has only moderate affinity, the cooperative effect of multiple simultaneous bonds means that all ten sites would have to dissociate at once for the antibody to release, which is statistically unlikely. This explains why IgM is an effective agglutinin despite being produced early in an immune response before extensive affinity maturation has occurred.

For forensic casework, the relationship between affinity and the detection limit of an assay matters directly. A lower Kd means the antibody will be occupied (bound to antigen) at lower antigen concentrations, pushing the assay's detection threshold lower. This is why laboratories specify the Kd of the antibodies in validated assay kits: it sets an expectation for the lowest antigen concentration the assay will reliably detect, which determines whether a trace biological sample is above or below the reporting threshold.

When an animal is immunised with an antigen, many B-cell clones respond, each producing antibodies targeting different epitopes on that antigen. The resulting antiserum is polyclonal: it contains many antibody species with different specificities, affinities, and isotypes. Polyclonal antisera were the standard forensic serology reagents through most of the twentieth century. They have one practical advantage: because they bind multiple epitopes, they can detect antigen even when some epitopes are degraded, making them tolerant of sample degradation.

Their main disadvantages are batch variability and ill-defined specificity. An antiserum prepared from one immunisation run differs from the next because the animal's immune response varies. This makes standardisation across laboratories difficult and means that published assay performance data may not apply to a different antiserum batch. Forensic laboratories using polyclonal reagents had to validate each new batch against known controls before use in casework, adding time and cost.

Monoclonal antibodies produced by hybridoma technology overcome batch variability. A hybridoma cell line is created by fusing a single antigen-specific B cell with a myeloma cell, generating an immortal clone that secretes one antibody indefinitely. Every molecule from that clone has the same heavy and light chains, the same CDR sequences, the same paratope geometry, and therefore the same Kd and the same epitope specificity. A forensic laboratory that validates a kit using lot 1 of a monoclonal antibody can expect lot 10 from the same clone to perform identically, provided manufacturing quality is maintained.

Specificity is the probability that an assay will give a negative result when the target analyte is absent. A highly specific assay does not bind structurally related molecules that are not the intended target. In practice, no antibody is perfectly specific: any molecule with a sufficiently similar epitope shape will bind to some degree. Cross-reactivity is the term for this off-target binding and is expressed as a percentage of the signal produced by the intended target at the same molar concentration.

In forensic drug screening, cross-reactivity profiles are critical. An immunoassay for benzodiazepines typically uses a monoclonal antibody raised against one compound in the class, such as diazepam or its glucuronide metabolite. The antibody may also bind other benzodiazepines such as alprazolam or lorazepam, with cross-reactivity values ranging from a few percent to over 100%. A positive screening result means only that a compound in the cross-reactive group is present above the cut-off; confirmatory testing by liquid chromatography coupled to mass spectrometry (LC-MS/MS) identifies the specific compound. Courts in multiple jurisdictions require confirmatory identification before a positive immunoassay result is used as evidence.

In species identification, precipitin tests use antisera or monoclonal antibodies raised against human serum proteins. Because humans share evolutionary history with other primates, some antibodies cross-react with non-human primate proteins. Classical double immunodiffusion and counterimmunoelectrophoresis tests using rabbit anti-human antiserum show visible precipitation with human blood but may show faint reactions with great-ape blood. Rigorous validation of species ID reagents includes testing against a panel of common animal species to establish the cross-reactivity boundaries. The precipitation reactions topic describes these methods in detail.

The choice of antibody class and format affects every immunoassay used in forensic practice. In ELISA formats, the capture antibody is typically a monoclonal IgG adsorbed to the microplate well. The detection antibody is a second monoclonal IgG targeting a different epitope on the same antigen, conjugated to horseradish peroxidase or alkaline phosphatase. This sandwich format requires that the antigen carry at least two epitopes accessible simultaneously, which limits the minimum antigen size to approximately 1 kDa. For small-molecule analytes such as drugs, a competitive ELISA format is used instead: the drug in the sample competes with drug conjugated to the well surface for binding to a fixed amount of antibody.

Lateral-flow immunoassay strips, widely used for roadside drug testing and body-fluid presumptive identification, operate on a competitive or sandwich principle using antibody-conjugated colloidal gold nanoparticles as the detection label. The antibody selectivity built into the strip determines which analytes trigger a visible signal. In drug testing strips cleared for workplace and roadside use by bodies such as the US Department of Transportation, the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA), and India's Ministry of Road Transport and Highways, the cut-off concentrations and cross-reactivity panels are defined by regulation and must be validated before the device is approved.

In body-fluid identification, lateral-flow strips targeting proteins specific to particular secretions illustrate how antibody class choice matters beyond the assay format. Tests for prostate-specific antigen (PSA) in semen use antibodies against the PSA protein, which is also present in trace concentrations in female urine and serum. A well-validated PSA assay has a cut-off calibrated to distinguish seminal concentrations (typically above 1 microgram per millilitre in fresh ejaculate) from background biological concentrations. Understanding the antibody's Kd and the assay's cut-off calibration is necessary to interpret a faint positive result in a vaginal swab from a case with possible recent intercourse. The ELISA principles and formats topic covers assay design in depth.